Regulatory Resources for Clinical Research during the COVID19 Pandemic

Provided are several resources that readers should review regarding the conduct of clinical research during the COVID19 pandemic.

·         Letter from Dr Ruth O’Hara regarding continuity of clinical research at Stanford

·         FDA guidance “Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic”

·         Stanford IRB guidance

·         Stanford Guidance for the Research Environment

·         Latest Stanford Updates

Stay healthy!